Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience.

IF 1.9 Q3 ENDOCRINOLOGY & METABOLISM Thyroid Research Pub Date : 2023-08-25 DOI:10.1186/s13044-023-00173-5
Moawia Mohammed Ali Elhassan, Mohamed Dafalla Awadalla Gismalla, Sahar Abdelrahman Hamid Mohamed, Areeg Faggad
{"title":"Clinicopathological profile and management of thyroid carcinoma: a Sub-Saharan country experience.","authors":"Moawia Mohammed Ali Elhassan, Mohamed Dafalla Awadalla Gismalla, Sahar Abdelrahman Hamid Mohamed, Areeg Faggad","doi":"10.1186/s13044-023-00173-5","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>In Sudan, there is limited knowledge on the epidemiology, clinical characteristics and pathological patterns of thyroid cancer. To address this shortcoming, we studied the clinical, pathological and treatment patterns of thyroid cancer at the National Cancer Institute ‒ University of Gezira (NCI-UG), Sudan.</p><p><strong>Methods: </strong>We performed a retrospective health facility-based study of patients with thyroid cancer who were treated at NCI-UG from January 2009 to December 2017.</p><p><strong>Results: </strong>A total of 139 patients with thyroid cancer were identified during the study period. Tumors were more common among women (69%). Goiter was the main presenting symptom (85%). The most common type of thyroid cancer was follicular carcinoma (41%), followed by papillary carcinoma (24%), then anaplastic carcinoma (20%). The mean age of the women was 56.3 years (SD ± 14.7), compared to 52.5 years (SD ± 16.6) for the men. The frequencies of stage I, II, III, and IV were 17%, 22%, 16%, and 45%, respectively. Different types of thyroidectomies were performed in 79% of the cases, lobectomy in 4%, and no surgery in 17%. Only 28% of the cases received radioactive iodine. Palliative chemotherapy and radiotherapy were prescribed to 17% and 37% of the cases, respectively.</p><p><strong>Conclusion: </strong>Thyroid cancer is more prevalent among women and most patients present at later stages. The dominance of follicular type suggests that the majority of this population is iodine-deficient.</p>","PeriodicalId":39048,"journal":{"name":"Thyroid Research","volume":"16 1","pages":"35"},"PeriodicalIF":1.9000,"publicationDate":"2023-08-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10463320/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Thyroid Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s13044-023-00173-5","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In Sudan, there is limited knowledge on the epidemiology, clinical characteristics and pathological patterns of thyroid cancer. To address this shortcoming, we studied the clinical, pathological and treatment patterns of thyroid cancer at the National Cancer Institute ‒ University of Gezira (NCI-UG), Sudan.

Methods: We performed a retrospective health facility-based study of patients with thyroid cancer who were treated at NCI-UG from January 2009 to December 2017.

Results: A total of 139 patients with thyroid cancer were identified during the study period. Tumors were more common among women (69%). Goiter was the main presenting symptom (85%). The most common type of thyroid cancer was follicular carcinoma (41%), followed by papillary carcinoma (24%), then anaplastic carcinoma (20%). The mean age of the women was 56.3 years (SD ± 14.7), compared to 52.5 years (SD ± 16.6) for the men. The frequencies of stage I, II, III, and IV were 17%, 22%, 16%, and 45%, respectively. Different types of thyroidectomies were performed in 79% of the cases, lobectomy in 4%, and no surgery in 17%. Only 28% of the cases received radioactive iodine. Palliative chemotherapy and radiotherapy were prescribed to 17% and 37% of the cases, respectively.

Conclusion: Thyroid cancer is more prevalent among women and most patients present at later stages. The dominance of follicular type suggests that the majority of this population is iodine-deficient.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
甲状腺癌的临床病理概况和管理:撒哈拉以南国家的经验。
背景:在苏丹,对甲状腺癌的流行病学、临床特征和病理模式的了解有限。为了解决这一缺陷,我们研究了苏丹国家癌症研究所-格齐拉大学(NCI-UG)甲状腺癌的临床、病理和治疗模式。方法:我们对2009年1月至2017年12月在NCI-UG接受治疗的甲状腺癌患者进行了一项基于医疗机构的回顾性研究。结果:研究期间共发现139例甲状腺癌患者。肿瘤在女性中更为常见(69%)。甲状腺肿大是主要症状(85%)。甲状腺癌最常见的类型是滤泡癌(41%),其次是乳头状癌(24%),然后是间变性癌(20%)。女性的平均年龄为56.3岁(SD±14.7),男性为52.5岁(SD±16.6)。I期、II期、III期和IV期的发生率分别为17%、22%、16%和45%。不同类型的甲状腺切除术占79%,肺叶切除术占4%,未手术的占17%。只有28%的病例接受了放射性碘治疗。姑息性化疗和放疗分别适用于17%和37%的病例。结论:甲状腺癌在女性中更为普遍,且大多数患者出现在晚期。卵泡型的优势表明,大多数人是缺碘的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Thyroid Research
Thyroid Research Medicine-Endocrinology, Diabetes and Metabolism
CiteScore
3.10
自引率
4.50%
发文量
21
审稿时长
8 weeks
期刊最新文献
Effectiveness of diffusion-weighted magnetic resonance imaging (DW-MRI) in the differentiation of thyroid nodules. Losartan is more effective than angiotensin (1-7) in preventing thyroxine-induced renal injury in the rat. The diagnostic performance of neck ultrasound in follow-up of advanced stage differentiated thyroid cancer. Sonographic characteristics of thyroid nodules with a Halo. Correlation between gene mutations and clinical characteristics in papillary thyroid cancer: a retrospective analysis of BRAF mutations and RET rearrangements.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1